BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6133269)

  • 41. Effect of ranitidine, a new H2-antagonist, on gastric and pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Sito E; Oleksy J; Miszczuk-Jamska B
    Dig Dis Sci; 1980 Oct; 25(10):737-43. PubMed ID: 6107221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of prolonged administration of ranitidine on pituitary and thyroid hormones, and their response to specific hypothalamic-releasing factors.
    Pasquali R; Corinaldesi R; Miglioli M; Melchionda N; Capelli M; Barbara L
    Clin Endocrinol (Oxf); 1981 Nov; 15(5):457-62. PubMed ID: 6120055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ranitidine in the maintenance therapy of gastro-duodenal ulcer disease: Polish open multicentre study.
    Gibiński K; Nowak A; Gabryelewicz A; Szałaj W; Hasik J; Klincewicz H; Butruk E; Kosecki P; Pokora J; Radwan P
    Hepatogastroenterology; 1984 Aug; 31(4):180-2. PubMed ID: 6090287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Duodenal ulcer: an update.
    Wormsley KG
    Mt Sinai J Med; 1981; 48(5):391-6. PubMed ID: 6117792
    [No Abstract]   [Full Text] [Related]  

  • 45. [A single evening dose of 300 mg ranitidine in the treatment of acute attacks of gastric and duodenal ulcers. Evaluation of 1,208 patients].
    Bories P; Tournade JM; Alberola B; Pappo M
    Ann Gastroenterol Hepatol (Paris); 1988 Oct; 24(5):227-32. PubMed ID: 3061358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ranitidine in the treatment of duodenal ulceration.
    Peden NR; Boyd EJ; Saunders JH; Wormsley KG
    Scand J Gastroenterol; 1981 Apr; 16(3):325-9. PubMed ID: 16435471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Healing of gastric ulcers after one, two, and three months of ranitidine.
    Ashton MG; Holdsworth CD; Ryan FP; Moore M
    Br Med J (Clin Res Ed); 1982 Feb; 284(6314):467-8. PubMed ID: 6120738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand.
    Kachintorn U; Chinapak O; Vongphanich V; Kositchaiwat C; Lekhayananda S; Khow-ean U; Suttinont C; Saowaros V; Kludchareon N; Leethochawalit M
    J Med Assoc Thai; 1995 Dec; 78(12):641-7. PubMed ID: 8868007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Josamycin combination with ranitidine in therapy of gastroduodenal ulcer: clinical efficiency].
    Maev IV; Vertkin AL; Vovk EI; Masharova AA; Bezborodnyĭ SD; Lebedeva EG
    Klin Med (Mosk); 2000; 78(3):46-50. PubMed ID: 10790966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of ranitidine on gastric mucus, pepsin and hydrochloric acid secretion in patients with duodenal ulcer.
    Gabryelewicz A; Sarosiek J; Laszewicz W
    Acta Med Pol; 1981; 22(4):335-9. PubMed ID: 6128866
    [No Abstract]   [Full Text] [Related]  

  • 51. H2-receptor antagonists: development and application.
    Feldman S
    N Engl Reg Allergy Proc; 1986; 7(4):362-6. PubMed ID: 2886903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ranitidine in uncomplicated duodenal ulceration. A double-blind endoscopically controlled trial.
    Moshal MG; Spitaels JM; Khan F
    S Afr Med J; 1981 Sep; 60(10):393-4. PubMed ID: 6269234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Nizatidine].
    Romero M; Franzosi MG
    Medicina (Firenze); 1989; 9(1):93-6. PubMed ID: 2567957
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Which drug for peptic ulcer?].
    Hameeteman W; Tytgat GN
    Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643
    [No Abstract]   [Full Text] [Related]  

  • 55. Controlled clinical trial of duodenal ulcer healing with antacid tablets.
    Berstad A; Rydning A; Aadland E; Kolstad B; Frislid K; Aaseth J
    Scand J Gastroenterol; 1982 Oct; 17(7):953-9. PubMed ID: 6130599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Duodenal and gastric ulcer healing rates: a review.
    Legerton CW
    Am J Med; 1984 Nov; 77(5B):2-7. PubMed ID: 6095656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ranitidine in the prevention of gastric and duodenal ulcer relapse.
    Alstead EM; Ryan FP; Holdsworth CD; Ashton MG; Moore M
    Gut; 1983 May; 24(5):418-20. PubMed ID: 6301956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Ranitidin--in cimetidine's foot steps].
    Cohen L; Eshchar J
    Harefuah; 1982 Jun; 102(12):543-7. PubMed ID: 6131019
    [No Abstract]   [Full Text] [Related]  

  • 59. Ranitidine in acute upper gastrointestinal haemorrhage.
    Langman MJ; Henry DA
    Br Med J (Clin Res Ed); 1982 Nov; 285(6354):1575-6. PubMed ID: 6128049
    [No Abstract]   [Full Text] [Related]  

  • 60. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.